Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Another European launch for Alphagan

April 23, 1998

Akorn acquires ophthalmic products from Alza

April 20, 1998

Cosopt receives marketing approval from FDA

April 16, 1998

Bio-Technology General signs U.S. marketing agreement with Akorn for BioLon

April 15, 1998

New ocular agents described by Novartis

March 30, 1998

QLT and Ciba Vision initiate phase IIIb verteporfin trial

March 20, 1998

FDA approves ocular antiinflammatory agent

March 11, 1998

Preliminary results reported from phase II trials of Vitrase

March 6, 1998

Improved vision in AMD patients in phase I/II using PhotoPoint technology

Feb. 25, 1998

Allergan's new antiglaucoma agents

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...